Dapaveldactin® 10 mg
RamedaDapaveldactin 10 mg contains dapagliflozin, an SGLT2 inhibitor that blocks the reabsorption of glucose in the kidneys, allowing excess glucose to be eliminated through the urine. This mechanism helps reduce blood glucose levels independently of insulin secretion. The medication is indicated not only for the treatment of type 2 diabetes mellitus, but also for reducing the risk of hospitalization for heart failure and slowing the progression of chronic kidney disease in eligible patients. It is administered orally once daily, with or without food, and should be used in combination with a healthy diet, regular exercise, and other prescribed medications when appropriate.
Ingredients
Active Ingredient Dapagliflozin 10 mg Inactive Ingredients Microcrystalline cellulose Lactose monohydrate Crospovidone Colloidal anhydrous silica Magnesium stearate Polyvinyl alcohol Titanium dioxide Macrogol (Polyethylene glycol) Talc Yellow iron oxide (tablet coating)
Indications
Dapaveldactin 10 mg is indicated for: Treatment of Type 2 Diabetes Mellitus as an adjunct to diet and exercise. Reduction of the risk of hospitalization for heart failure in adults with heart failure. Treatment of Chronic Kidney Disease (CKD) to reduce the progression of kidney disease and cardiovascular complications in eligible patients. Reduction of cardiovascular events in selected high-risk patients with type 2 diabetes
Precautions
Assess kidney function before starting treatment and monitor periodically. Maintain adequate hydration to reduce the risk of dehydration and low blood pressure. Use cautiously in elderly patients and those taking diuretics. Monitor for urinary tract infections and genital fungal infections. Discontinue temporarily before major surgery or prolonged fasting due to the risk of diabetic ketoacidosis. Not recommended for patients with type 1 diabetes because of an increased risk of diabetic ketoacidosis. Use during pregnancy or breastfeeding only if the potential benefits outweigh the risks and under medical supervision. Seek immediate medical attention if symptoms of diabetic ketoacidosis occur, including nausea, vomiting, abdominal pain, rapid breathing, or unusual fatigue.